Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Download original image
Fig. 5. Subgroup analysis of functional dyspepsia. (A) The proportion of responders in the DA-9701 group was 50.00%, which was higher than 31.03% in the placebo group (P = 0.138). (B-D) Changes in the severity of symptoms including epigastric pain or soreness, early satiety, and postprandial fullness were not significantly different between the 2 groups. Change 1 = 1 week – baseline; Change 2 = 2 weeks – baseline; Change 3 = 3 weeks – baseline; Change 4 = 4 weeks – baseline.
J Neurogastroenterol Motil 2022;28:265~275 https://doi.org/10.5056/jnm20236
© J Neurogastroenterol Motil